Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice…
No Comments »
Filed under: Men's Health
A new study from the Journal of Traumatic Stress finds that for active-duty male soldiers in the U.S. Army who are happily married, communicating frequently with one’s spouse through letters and emails during deployment may protect against the development of posttraumatic stress disorder (PTSD) symptoms after returning home…
No Comments »
Filed under: Men's Health
Low testosterone levels and symptoms of male sexual dysfunction due to obesity may be reversible with weight loss after bariatric surgery, a new study finds. The results were presented Saturday at The Endocrine Society’s 93rd Annual Meeting in Boston…
No Comments »
Filed under: Men's Health
Estrogen therapy improves low bone density due to anorexia nervosa in teenage girls with the disease when given as a patch or as a low oral dose that is physiological (close to the form or amount of estrogen the body makes naturally). These results of a new study are being presented Monday at The Endocrine [...]
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The federal government dished out some anticipated nutrition news this week when it released its brand new health icon to replace the confusing food pyramid, the American Medical Association names a new executive vice president, and CMS said it would go a little easier on doctors who aren’t ready to ditch [...]
No Comments »
Filed under: General Health News
Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
No Comments »
Filed under: Pharmacy News
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
No Comments »
Filed under: Pharmacy News
Genetic analysis of the tumors from patients with advanced melanoma can clue researchers in to how well patients will respond to a therapy that targets the growth-promoting protein called BRAF, a researcher from the Perelman School of Medicine at the University of Pennsylvania will report on Monday, June 6 at the annual meeting of the [...]
No Comments »
Filed under: Pharmacy News
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced that IPX066 ADVANCE-PD and APEX-PD Phase III clinical study data will be presented in Poster Sessions at the 15th International Congress of Parkinson’s Disease and Movement Disorders Conference in Toronto, Canada, held from June 5 to June 9.
No Comments »
Filed under: Pharmacy News
Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.
No Comments »
Filed under: Pharmacy News
